Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 875171Generated: October 29, 2026

Diisopropylethylamine → N-((2'-Cyano(1,1'-biphenyl)-4-yl)methyl)-L-valine methyl ester

https://huagongshe.com/reaction/875171

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDiisopropylethylamineHCID 81531—
ReactantMethyl valinate hydrochlorideHCID 111190—
Reactant4'-(Bromomethyl)-2-cyanobiphenylHCID 1501912—
ReactantHCID 178447302HCID 178447302—
SolventDichloromethaneHCID 6344—
ProductN-((2'-Cyano(1,1'-biphenyl)-4-yl)methyl)-L-valine methyl esterHCID 16744794—

Reaction Steps

Bioorganic & Medicinal Chemistry Letters (1994), 4(1), 29-34, reported a process for the preparation of Valsartan by reacting 4′-bromomethyl-2-cyanobiphenyl (II) with (L)-valine methyl ester hydrochloride (V) in the presence of diisopropylethylamine in methylenechloride to produce N-[(2′-cyanobiphenyl-4-yl)methyl]-(L)-valine methyl ester (VI), followed by reacting with valeryl chloride in the presence of diisopropylethylamine in methylenechloride to produce N-valeryl-N-[(2′-cyanobiphenyl-4-yl)methyl]-(L)-valine methyl ester (VII), which is further reacted with tributyltin azide in xylene to produce N-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-N-valeryl-(L)-valine methyl ester (VIII), followed by hydrolysis with aqueous base to produce Valsartan of formula (I).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08981109B2
Source datasetuspto-grants-2015_03
ORD IDord-5634e96350e143768c8515802b7759c6
Source noteuspto-grants-2015_03